{"id":22144,"date":"2021-11-12T17:41:21","date_gmt":"2021-11-12T17:41:21","guid":{"rendered":"https:\/\/sbpt.org.br\/portal\/?p=22144"},"modified":"2021-11-12T17:41:21","modified_gmt":"2021-11-12T17:41:21","slug":"consulta-publica-riociguate-hptec","status":"publish","type":"post","link":"https:\/\/sbpt.org.br\/portal\/consulta-publica-riociguate-hptec\/","title":{"rendered":"Conitec abre Consulta P\u00fablica para incorpora\u00e7\u00e3o de medicamento para HPTEC"},"content":{"rendered":"<p style=\"text-align: justify\">A Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade (Conitec) abriu uma Consulta P\u00fablica sobre a incorpora\u00e7\u00e3o do medicamento de via oral riociguate para o tratamento da Hipertens\u00e3o Pulmonar Tromboemb\u00f3lica Cr\u00f4nica (HPTEC) inoper\u00e1vel, persistente ou recorrente ap\u00f3s tratamento cir\u00fargico.<\/p>\n<p>O prazo para contribuir \u00e9 23\/11\/2021.<\/p>\n<p style=\"text-align: center\"><a href=\"http:\/\/www.conitec.gov.br\/consultas-publicas\" target=\"_blank\" rel=\"noopener noreferrer\">Clique aqui para preencher o formul\u00e1rio com a sua opini\u00e3o.<\/a><\/p>\n<p><span class=\"text-format-content\"><a href=\"http:\/\/conitec.gov.br\/images\/Consultas\/Relatorios\/2021\/20211103_Relatorio_riociguate_HPTEC_inoperavel_persistente_recorrente_CP90.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Leia o Relat\u00f3rio T\u00e9cnico<\/a>.<\/p>\n<p><a href=\"http:\/\/conitec.gov.br\/images\/Consultas\/Relatorios\/2021\/Sociedade\/20211104_ReSoc306_riociguate_HPTEC.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Leia o Relat\u00f3rio para a Sociedade<\/a>.<\/span><\/p>\n<!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>A Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade (Conitec) abriu uma Consulta P\u00fablica sobre a incorpora\u00e7\u00e3o do medicamento de via oral riociguate para o tratamento da Hipertens\u00e3o Pulmonar Tromboemb\u00f3lica Cr\u00f4nica (HPTEC) inoper\u00e1vel, persistente ou recorrente ap\u00f3s tratamento cir\u00fargico. O prazo para contribuir \u00e9 23\/11\/2021. Clique aqui para preencher o formul\u00e1rio com [&hellip;]<!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>\n","protected":false},"author":3,"featured_media":19942,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"ngg_post_thumbnail":0,"footnotes":""},"categories":[68],"tags":[416,94,95,748],"class_list":["post-22144","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias","tag-hap","tag-hipertensao-pulmonar","tag-hp","tag-riociguate"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Conitec abre Consulta P\u00fablica para incorpora\u00e7\u00e3o de medicamento para HPTEC<\/title>\n<meta name=\"description\" content=\"A Conitec abriu uma Consulta P\u00fablica sobre a incorpora\u00e7\u00e3o no SUS do medicamento de via oral riociguate para o tratamento da Hipertens\u00e3o Pulmonar Tromboemb\u00f3lica Cr\u00f4nica (HPTEC) inoper\u00e1vel, persistente ou recorrente ap\u00f3s tratamento cir\u00fargico.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sbpt.org.br\/portal\/consulta-publica-riociguate-hptec\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Conitec abre Consulta P\u00fablica para incorpora\u00e7\u00e3o de medicamento para HPTEC\" \/>\n<meta property=\"og:description\" content=\"A Conitec abriu uma Consulta P\u00fablica sobre a incorpora\u00e7\u00e3o no SUS do medicamento de via oral riociguate para o tratamento da Hipertens\u00e3o Pulmonar Tromboemb\u00f3lica Cr\u00f4nica (HPTEC) inoper\u00e1vel, persistente ou recorrente ap\u00f3s tratamento cir\u00fargico.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sbpt.org.br\/portal\/consulta-publica-riociguate-hptec\/\" \/>\n<meta property=\"og:site_name\" content=\"sbpt.org.br\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pneumosbpt\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-12T17:41:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/06\/conitec.png\" \/>\n\t<meta property=\"og:image:width\" content=\"350\" \/>\n\t<meta property=\"og:image:height\" content=\"255\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Comunica\u00e7\u00e3o SBPT\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pneumosbpt\" \/>\n<meta name=\"twitter:site\" content=\"@pneumosbpt\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Comunica\u00e7\u00e3o SBPT\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-riociguate-hptec\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-riociguate-hptec\\\/\"},\"author\":{\"name\":\"Comunica\u00e7\u00e3o SBPT\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/person\\\/adba7f33cf32721354590c6f0eb852d4\"},\"headline\":\"Conitec abre Consulta P\u00fablica para incorpora\u00e7\u00e3o de medicamento para HPTEC\",\"datePublished\":\"2021-11-12T17:41:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-riociguate-hptec\\\/\"},\"wordCount\":94,\"publisher\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-riociguate-hptec\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/d1xe7tfg0uwul9.cloudfront.net\\\/sbpt.org.br\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/06121940\\\/conitec-e1791299980747.png\",\"keywords\":[\"HAP\",\"hipertens\u00e3o pulmonar\",\"HP\",\"riociguate\"],\"articleSection\":[\"Not\u00edcias\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-riociguate-hptec\\\/\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-riociguate-hptec\\\/\",\"name\":\"Conitec abre Consulta P\u00fablica para incorpora\u00e7\u00e3o de medicamento para HPTEC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-riociguate-hptec\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-riociguate-hptec\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/d1xe7tfg0uwul9.cloudfront.net\\\/sbpt.org.br\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/06121940\\\/conitec-e1791299980747.png\",\"datePublished\":\"2021-11-12T17:41:21+00:00\",\"description\":\"A Conitec abriu uma Consulta P\u00fablica sobre a incorpora\u00e7\u00e3o no SUS do medicamento de via oral riociguate para o tratamento da Hipertens\u00e3o Pulmonar Tromboemb\u00f3lica Cr\u00f4nica (HPTEC) inoper\u00e1vel, persistente ou recorrente ap\u00f3s tratamento cir\u00fargico.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-riociguate-hptec\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-riociguate-hptec\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-riociguate-hptec\\\/#primaryimage\",\"url\":\"https:\\\/\\\/d1xe7tfg0uwul9.cloudfront.net\\\/sbpt.org.br\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/06121940\\\/conitec-e1791299980747.png\",\"contentUrl\":\"https:\\\/\\\/d1xe7tfg0uwul9.cloudfront.net\\\/sbpt.org.br\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/06121940\\\/conitec-e1791299980747.png\",\"width\":343,\"height\":231},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/consulta-publica-riociguate-hptec\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Conitec abre Consulta P\u00fablica para incorpora\u00e7\u00e3o de medicamento para HPTEC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#website\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\",\"name\":\"sbpt.org.br\",\"description\":\"Sociedade Brasileira de Pneumologia e Tisiologia\",\"publisher\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\"},\"alternateName\":\"SBPT\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\",\"name\":\"sbpt.org.br\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/logo-sbpt.png\",\"contentUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/logo-sbpt.png\",\"width\":512,\"height\":512,\"caption\":\"sbpt.org.br\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/pneumosbpt\",\"https:\\\/\\\/x.com\\\/pneumosbpt\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pneumosbpt\\\/\",\"https:\\\/\\\/www.instagram.com\\\/pneumosbpt\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/socbraspneumol\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/person\\\/adba7f33cf32721354590c6f0eb852d4\",\"name\":\"Comunica\u00e7\u00e3o SBPT\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g\",\"caption\":\"Comunica\u00e7\u00e3o SBPT\"},\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/author\\\/anahelena\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Conitec abre Consulta P\u00fablica para incorpora\u00e7\u00e3o de medicamento para HPTEC","description":"A Conitec abriu uma Consulta P\u00fablica sobre a incorpora\u00e7\u00e3o no SUS do medicamento de via oral riociguate para o tratamento da Hipertens\u00e3o Pulmonar Tromboemb\u00f3lica Cr\u00f4nica (HPTEC) inoper\u00e1vel, persistente ou recorrente ap\u00f3s tratamento cir\u00fargico.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sbpt.org.br\/portal\/consulta-publica-riociguate-hptec\/","og_locale":"pt_BR","og_type":"article","og_title":"Conitec abre Consulta P\u00fablica para incorpora\u00e7\u00e3o de medicamento para HPTEC","og_description":"A Conitec abriu uma Consulta P\u00fablica sobre a incorpora\u00e7\u00e3o no SUS do medicamento de via oral riociguate para o tratamento da Hipertens\u00e3o Pulmonar Tromboemb\u00f3lica Cr\u00f4nica (HPTEC) inoper\u00e1vel, persistente ou recorrente ap\u00f3s tratamento cir\u00fargico.","og_url":"https:\/\/sbpt.org.br\/portal\/consulta-publica-riociguate-hptec\/","og_site_name":"sbpt.org.br","article_publisher":"https:\/\/www.facebook.com\/pneumosbpt","article_published_time":"2021-11-12T17:41:21+00:00","og_image":[{"width":350,"height":255,"url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/06\/conitec.png","type":"image\/png"}],"author":"Comunica\u00e7\u00e3o SBPT","twitter_card":"summary_large_image","twitter_creator":"@pneumosbpt","twitter_site":"@pneumosbpt","twitter_misc":{"Escrito por":"Comunica\u00e7\u00e3o SBPT"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-riociguate-hptec\/#article","isPartOf":{"@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-riociguate-hptec\/"},"author":{"name":"Comunica\u00e7\u00e3o SBPT","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/person\/adba7f33cf32721354590c6f0eb852d4"},"headline":"Conitec abre Consulta P\u00fablica para incorpora\u00e7\u00e3o de medicamento para HPTEC","datePublished":"2021-11-12T17:41:21+00:00","mainEntityOfPage":{"@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-riociguate-hptec\/"},"wordCount":94,"publisher":{"@id":"https:\/\/sbpt.org.br\/portal\/#organization"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-riociguate-hptec\/#primaryimage"},"thumbnailUrl":"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/wp-content\/uploads\/2021\/06\/06121940\/conitec-e1791299980747.png","keywords":["HAP","hipertens\u00e3o pulmonar","HP","riociguate"],"articleSection":["Not\u00edcias"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-riociguate-hptec\/","url":"https:\/\/sbpt.org.br\/portal\/consulta-publica-riociguate-hptec\/","name":"Conitec abre Consulta P\u00fablica para incorpora\u00e7\u00e3o de medicamento para HPTEC","isPartOf":{"@id":"https:\/\/sbpt.org.br\/portal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-riociguate-hptec\/#primaryimage"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-riociguate-hptec\/#primaryimage"},"thumbnailUrl":"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/wp-content\/uploads\/2021\/06\/06121940\/conitec-e1791299980747.png","datePublished":"2021-11-12T17:41:21+00:00","description":"A Conitec abriu uma Consulta P\u00fablica sobre a incorpora\u00e7\u00e3o no SUS do medicamento de via oral riociguate para o tratamento da Hipertens\u00e3o Pulmonar Tromboemb\u00f3lica Cr\u00f4nica (HPTEC) inoper\u00e1vel, persistente ou recorrente ap\u00f3s tratamento cir\u00fargico.","breadcrumb":{"@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-riociguate-hptec\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sbpt.org.br\/portal\/consulta-publica-riociguate-hptec\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-riociguate-hptec\/#primaryimage","url":"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/wp-content\/uploads\/2021\/06\/06121940\/conitec-e1791299980747.png","contentUrl":"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/wp-content\/uploads\/2021\/06\/06121940\/conitec-e1791299980747.png","width":343,"height":231},{"@type":"BreadcrumbList","@id":"https:\/\/sbpt.org.br\/portal\/consulta-publica-riociguate-hptec\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sbpt.org.br\/portal\/"},{"@type":"ListItem","position":2,"name":"Conitec abre Consulta P\u00fablica para incorpora\u00e7\u00e3o de medicamento para HPTEC"}]},{"@type":"WebSite","@id":"https:\/\/sbpt.org.br\/portal\/#website","url":"https:\/\/sbpt.org.br\/portal\/","name":"sbpt.org.br","description":"Sociedade Brasileira de Pneumologia e Tisiologia","publisher":{"@id":"https:\/\/sbpt.org.br\/portal\/#organization"},"alternateName":"SBPT","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sbpt.org.br\/portal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/sbpt.org.br\/portal\/#organization","name":"sbpt.org.br","url":"https:\/\/sbpt.org.br\/portal\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/logo\/image\/","url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2026\/10\/logo-sbpt.png","contentUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2026\/10\/logo-sbpt.png","width":512,"height":512,"caption":"sbpt.org.br"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pneumosbpt","https:\/\/x.com\/pneumosbpt","https:\/\/www.linkedin.com\/company\/pneumosbpt\/","https:\/\/www.instagram.com\/pneumosbpt\/","https:\/\/www.youtube.com\/user\/socbraspneumol"]},{"@type":"Person","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/person\/adba7f33cf32721354590c6f0eb852d4","name":"Comunica\u00e7\u00e3o SBPT","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g","caption":"Comunica\u00e7\u00e3o SBPT"},"url":"https:\/\/sbpt.org.br\/portal\/author\/anahelena\/"}]}},"_links":{"self":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts\/22144","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/comments?post=22144"}],"version-history":[{"count":0,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts\/22144\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/media\/19942"}],"wp:attachment":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/media?parent=22144"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/categories?post=22144"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/tags?post=22144"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}